Primary Site >> Colorectal Cancer
Gene >> IDO1
| 1. | |||||||||||
| Journal: | Gene. 1991 Sep 15;105(2):221-7. | ||||||||||
| Title: | Cloning and expression of a cDNA encoding mouse indoleamine 2,3-dioxygenase. | ||||||||||
| Author: | Habara-Ohkubo, A|Takikawa, O|Yoshida, R | ||||||||||
| PMID: | 1937018 | ||||||||||
| 2. | |||||||||||
| Journal: | Infect Immun. 1993 May;61(5):1810-3. | ||||||||||
| Title: | Establishment of an antitoxoplasma state by stable expression of mouse indoleamine 2,3-dioxygenase. | ||||||||||
| Author: | Habara-Ohkubo, A|Shirahata, T|Takikawa, O|Yoshida, R | ||||||||||
| PMID: | 8478070 | ||||||||||
| 3. | |||||||||||
| Journal: | Clin Cancer Res. 2006 Feb 15;12(4):1144-51. | ||||||||||
| Title: | Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells. | ||||||||||
| Author: | Brandacher, Gerald|Perathoner, Alexander|Ladurner, Ruth|Schneeberger, Stefan|Obrist, Peter|Winkler, Christiana|Werner, Ernst R|Werner-Felmayer, Gabriele|Weiss, Helmut G|Gobel, Georg|Margreiter, Raimund|Konigsrainer, Alfred|Fuchs, Dietmar|Amberger, Albert | ||||||||||
| PMID: | 16489067 | ||||||||||
| 4. | |||||||||||
| Journal: | Cancer Immun. 2007 Jun 26;7:10. | ||||||||||
| Title: | Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human bladder cancer. | ||||||||||
| Author: | Liakou, Chrysoula I|Narayanan, Sowmita|Ng Tang, Derek|Logothetis, Christopher J|Sharma, Padmanee | ||||||||||
| PMID: | 17591743 | ||||||||||
| 5. | |||||||||||
| Journal: | Cytotechnology. 2007 Jun;54(2):107-13. | ||||||||||
| Title: | Transcriptional regulation of indoleamine 2,3-dioxygenase (IDO) by tryptophan and its analogue : Down-regulation of the indoleamine 2,3-dioxygenase (IDO) transcription by tryptophan and its analogue. | ||||||||||
| Author: | Okamoto, Takeaki|Tone, Shigenobu|Kanouchi, Hiroaki|Miyawaki, Chie|Ono, Sayuri|Minatogawa, Yohsuke | ||||||||||
| PMID: | 19003025 | ||||||||||
| 6. | |||||||||||
| Journal: | Cancer Immunol Immunother. 2009 Jan;58(1):153-7. | ||||||||||
| Title: | IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism. | ||||||||||
| Author: | Lob, Stefan|Konigsrainer, Alfred|Zieker, Derek|Brucher, Bjorn L D M|Rammensee, Hans-Georg|Opelz, Gerhard|Terness, Peter | ||||||||||
| PMID: | 18418598 | ||||||||||
| 7. | |||||||||||
| Journal: | Clin Cancer Res. 2009 Jan 15;15(2):641-9. | ||||||||||
| Title: | A novel cancer therapy by skin delivery of indoleamine 2,3-dioxygenase siRNA. | ||||||||||
| Author: | Yen, Meng-Chi|Lin, Chi-Chen|Chen, Yi-Ling|Huang, Shih-Shien|Yang, Huei-Jiun|Chang, Chih-Peng|Lei, Huan-Yao|Lai, Ming-Derg | ||||||||||
| PMID: | 19147770 | ||||||||||
| 8. | |||||||||||
| Journal: | J Transl Med. 2009 Aug 20;7:71. | ||||||||||
| Title: | The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer. | ||||||||||
| Author: | Gao, Yan-Fang|Peng, Rui-Qing|Li, Jiang|Ding, Ya|Zhang, Xing|Wu, Xiao-Jun|Pan, Zhi-Zhong|Wan, De-Sen|Zeng, Yi-Xin|Zhang, Xiao-Shi | ||||||||||
| PMID: | 19695096 | ||||||||||
| 9. | |||||||||||
| Journal: | Mol Cancer Ther. 2010 Feb;9(2):489-98. | ||||||||||
| Title: | Hydroxyamidine inhibitors of indoleamine-2,3-dioxygenase potently suppress systemic tryptophan catabolism and the growth of IDO-expressing tumors. | ||||||||||
| Author: | Koblish, Holly K|Hansbury, Michael J|Bowman, Kevin J|Yang, Gengjie|Neilan, Claire L|Haley, Patrick J|Burn, Timothy C|Waeltz, Paul|Sparks, Richard B|Yue, Eddy W|Combs, Andrew P|Scherle, Peggy A|Vaddi, Kris|Fridman, Jordan S | ||||||||||
| PMID: | 20124451 | ||||||||||
| 10. | |||||||||||
| Journal: | Cancer Sci. 2011 Dec;102(12):2214-20. | ||||||||||
| Title: | Skin delivery of short hairpin RNA of indoleamine 2,3 dioxygenase induces antitumor immunity against orthotopic and metastatic liver cancer. | ||||||||||
| Author: | Huang, Tzu-Ting|Yen, Meng-Chi|Lin, Chi-Chen|Weng, Tzu-Yang|Chen, Yi-Ling|Lin, Chiu-Mei|Lai, Ming-Derg | ||||||||||
| PMID: | 21899659 | ||||||||||
| 11. | |||||||||||
| Journal: | Br J Cancer. 2012 Jan 3;106(1):141-7. | ||||||||||
| Title: | Clinicopathological significance of indoleamine 2,3-dioxygenase 1 expression in colorectal cancer. | ||||||||||
| Author: | Ferdinande, L|Decaestecker, C|Verset, L|Mathieu, A|Moles Lopez, X|Negulescu, A-M|Van Maerken, T|Salmon, I|Cuvelier, C A|Demetter, P | ||||||||||
| PMID: | 22108515 | ||||||||||
| 12. | |||||||||||
| Journal: | Oncol Lett. 2012 Sep;4(3):546-550. | ||||||||||
| Title: | (-)-Epigallocatechin gallate inhibits the expression of indoleamine 2,3-dioxygenase in human colorectal cancer cells. | ||||||||||
| Author: | Ogawa, Kengo|Hara, Takeshi|Shimizu, Masahito|Nagano, Junji|Ohno, Tomohiko|Hoshi, Masato|Ito, Hiroyasu|Tsurumi, Hisashi|Saito, Kuniaki|Seishima, Mitsuru|Moriwaki, Hisataka | ||||||||||
| PMID: | 23741252 | ||||||||||
| 13. | |||||||||||
| Journal: | Cancer Sci. 2012 May;103(5):951-8. | ||||||||||
| Title: | Suppression of azoxymethane-induced colonic preneoplastic lesions in rats by 1-methyltryptophan, an inhibitor of indoleamine 2,3-dioxygenase. | ||||||||||
| Author: | Ogawa, Kengo|Hara, Takeshi|Shimizu, Masahito|Ninomiya, Soranobu|Nagano, Junji|Sakai, Hiroyasu|Hoshi, Masato|Ito, Hiroyasu|Tsurumi, Hisashi|Saito, Kuniaki|Seishima, Mitsuru|Tanaka, Takuji|Moriwaki, Hisataka | ||||||||||
| PMID: | 22320717 | ||||||||||
| 14. | |||||||||||
| Journal: | Biochem Cell Biol. 2012 Apr;90(2):173-8. | ||||||||||
| Title: | Changes in the levels of thioredoxin and indoleamine-2,3-dioxygenase activity in plasma of patients with colorectal cancer treated with chemotherapy. | ||||||||||
| Author: | Cavia-Saiz, Monica|Muniz, Pilar|De Santiago, Reyes|Herreros-Villanueva, Marta|Garcia-Giron, Carlos|Lopez, Ana Sofia|Coma-Del Corral, Maria Jesus | ||||||||||
| PMID: | 22257103 | ||||||||||
| 15. | |||||||||||
| Journal: | Curr Opin Gastroenterol. 2013 Mar;29(2):146-52. | ||||||||||
| Title: | Indoleamine 2,3 dioxygenase in intestinal disease. | ||||||||||
| Author: | Ciorba, Matthew A | ||||||||||
| PMID: | 23283180 | ||||||||||
| 16. | |||||||||||
| Journal: | Gastroenterology. 2013 Aug;145(2):416-25.e1-4. | ||||||||||
| Title: | IDO1 metabolites activate beta-catenin signaling to promote cancer cell proliferation and colon tumorigenesis in mice. | ||||||||||
| Author: | Thaker, Ameet I|Rao, M Suprada|Bishnupuri, Kumar S|Kerr, Thomas A|Foster, Lynne|Marinshaw, Jeffrey M|Newberry, Rodney D|Stenson, William F|Ciorba, Matthew A | ||||||||||
| PMID: | 23669411 | ||||||||||
| 17. | |||||||||||
| Journal: | Mol Biol Rep. 2014;41(4):2275-9. | ||||||||||
| Title: | The role of plasma IDO activity as a diagnostic marker of patients with colorectal cancer. | ||||||||||
| Author: | Cavia-Saiz, M|Muniz Rodriguez, P|Llorente Ayala, B|Garcia-Gonzalez, M|Coma-Del Corral, M J|Garcia Giron, C | ||||||||||
| PMID: | 24435977 | ||||||||||
| 18. | |||||||||||
| Journal: | Oncotarget. 2015 Oct 20;6(32):32561-74. | ||||||||||
| Title: | An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancer. | ||||||||||
| Author: | Agostini, Marco|Janssen, Klaus-Peter|Kim, Il-Jin|D'Angelo, Edoardo|Pizzini, Silvia|Zangrando, Andrea|Zanon, Carlo|Pastrello, Chiara|Maretto, Isacco|Digito, Maura|Bedin, Chiara|Jurisica, Igor|Rizzolio, Flavio|Giordano, Antonio|Bortoluzzi, Stefania|Nitti, D | ||||||||||
| PMID: | 26359356 | ||||||||||
| 19. | |||||||||||
| Journal: | Am J Cancer Res. 2015 Jun 15;5(7):2222-8. eCollection 2015. | ||||||||||
| Title: | The treatment of mouse colorectal cancer by oral delivery tumor-targeting Salmonella. | ||||||||||
| Author: | Wang, Wei-Kuang|Lu, Meng-Fan|Kuan, Yu-Diao|Lee, Che-Hsin | ||||||||||
| PMID: | 26328252 | ||||||||||
| 20. | |||||||||||
| Journal: | Cancer Sci. 2015 Aug;106(8):1008-15. | ||||||||||
| Title: | Inhibition of indoleamine 2,3-dioxygenase 1 expression alters immune response in colon tumor microenvironment in mice. | ||||||||||
| Author: | Takamatsu, Manabu|Hirata, Akihiro|Ohtaki, Hirofumi|Hoshi, Masato|Ando, Tatsuya|Ito, Hiroyasu|Hatano, Yuichiro|Tomita, Hiroyuki|Kuno, Toshiya|Saito, Kuniaki|Seishima, Mitsuru|Hara, Akira | ||||||||||
| PMID: | 26033215 | ||||||||||
| 21. | |||||||||||
| Journal: | PLoS One. 2015 Apr 16;10(4):e0122046. | ||||||||||
| Title: | Accumulation of an endogenous tryptophan-derived metabolite in colorectal and breast cancers. | ||||||||||
| Author: | Puccetti, Paolo|Fallarino, Francesca|Italiano, Antoine|Soubeyran, Isabelle|MacGrogan, Gaetan|Debled, Marc|Velasco, Valerie|Bodet, Dominique|Eimer, Sandrine|Veldhoen, Marc|Prendergast, Georges C|Platten, Michael|Bessede, Alban|Guillemin, Gilles J | ||||||||||
| PMID: | 25881064 | ||||||||||
| 22. | |||||||||||
| Journal: | Cancer Discov. 2015 Jan;5(1):16-8. | ||||||||||
| Title: | The microsatellite instable subset of colorectal cancer is a particularly good candidate for checkpoint blockade immunotherapy. | ||||||||||
| Author: | Xiao, Yanping|Freeman, Gordon J | ||||||||||
| PMID: | 25583798 | ||||||||||
| 23. | |||||||||||
| Journal: | Biochem J. 2015 Jul 15;469(2):267-78. | ||||||||||
| Title: | Slc5a8, a Na+-coupled high-affinity transporter for short-chain fatty acids, is a conditional tumour suppressor in colon that protects against colitis and colon cancer under low-fibre dietary conditions. | ||||||||||
| Author: | Gurav, Ashish|Sivaprakasam, Sathish|Bhutia, Yangzom D|Boettger, Thomas|Singh, Nagendra|Ganapathy, Vadivel | ||||||||||
| PMID: | 25984582 | ||||||||||
| 24. | |||||||||||
| Journal: | Transl Res. 2016 Jan;167(1):67-79. | ||||||||||
| Title: | Therapeutic targeting of inflammation and tryptophan metabolism in colon and gastrointestinal cancer. | ||||||||||
| Author: | Santhanam, Srikanth|Alvarado, David M|Ciorba, Matthew A | ||||||||||
| PMID: | 26297050 | ||||||||||
| 25. | |||||||||||
| Journal: | Mod Pathol. 2016 May;29(5):528-41. | ||||||||||
| Title: | Medullary carcinoma of the colon: a distinct morphology reveals a distinctive immunoregulatory microenvironment. | ||||||||||
| Author: | Friedman, Kenneth|Brodsky, Alexander S|Lu, Shaolei|Wood, Stephanie|Gill, Anthony J|Lombardo, Kara|Yang, Dongfang|Resnick, Murray B | ||||||||||
| PMID: | 26965581 | ||||||||||
| 26. | |||||||||||
| Journal: | J Cancer Res Clin Oncol. 2016 Aug;142(8):1775-80. | ||||||||||
| Title: | Prognostic relevance of genetic variants involved in immune checkpoints in patients with colorectal cancer. | ||||||||||
| Author: | Yoon, Shinkyo|Kang, Byung Woog|Park, Su Yeon|Kim, Hye Jin|Park, Jun Seok|Choi, Gyu Seog|Kim, Jong Gwang | ||||||||||
| PMID: | 27339628 | ||||||||||
| 27. | |||||||||||
| Journal: | J Am Chem Soc. 2016 Sep 28;138(38):12502-10. | ||||||||||
| Title: | Chlorin-Based Nanoscale Metal-Organic Framework Systemically Rejects Colorectal Cancers via Synergistic Photodynamic Therapy and Checkpoint Blockade Immunotherapy. | ||||||||||
| Author: | Lu, Kuangda|He, Chunbai|Guo, Nining|Chan, Christina|Ni, Kaiyuan|Weichselbaum, Ralph R|Lin, Wenbin | ||||||||||
| PMID: | 27575718 | ||||||||||
| 28. | |||||||||||
| Journal: | Dis Markers. 2016;2016:8169724. | ||||||||||
| Title: | Expression Pattern and Clinicopathological Relevance of the Indoleamine 2,3-Dioxygenase 1/Tryptophan 2,3-Dioxygenase Protein in Colorectal Cancer. | ||||||||||
| Author: | Chen, I-Chien|Lee, Kuen-Haur|Hsu, Ying-Hua|Wang, Wei-Ran|Chen, Chuan-Mu|Cheng, Ya-Wen | ||||||||||
| PMID: | 27578919 | ||||||||||
| 29. | |||||||||||
| Journal: | Brain Behav Immun. 2017 May;62:78-86. | ||||||||||
| Title: | Epinephrine promotes COX-2-dependent immune suppression in myeloid cells and cancer tissues. | ||||||||||
| Author: | Muthuswamy, Ravikumar|Okada, Nana J|Jenkins, Frank J|McGuire, Kandace|McAuliffe, Priscilla F|Zeh, Herbert J|Bartlett, David L|Wallace, Callen|Watkins, Simon|Henning, Jill D|Bovbjerg, Dana H|Kalinski, Pawel | ||||||||||
| PMID: | 28212885 | ||||||||||
| 30. | |||||||||||
| Journal: | Mol Clin Oncol. 2017 May;6(5):701-704. | ||||||||||
| Title: | Expression of CXCR-4 and IDO in human colorectal cancer: An immunohistochemical approach. | ||||||||||
| Author: | Ogawa, Masaichi|Watanabe, Michiaki|Hasegawa, Takuo|Ichihara, Kohei|Yoshida, Kazuhiko|Yanaga, Katsuhiko | ||||||||||
| PMID: | 28515923 | ||||||||||
| 31. | |||||||||||
| Journal: | Cell Cycle. 2017 Jul 3;16(13):1295-1301. | ||||||||||
| Title: | Long noncoding RNA lnc-sox5 modulates CRC tumorigenesis by unbalancing tumor microenvironment. | ||||||||||
| Author: | Wu, Kaiming|Zhao, Zhenxian|Liu, Kuanzhi|Zhang, Jian|Li, Guanghua|Wang, Liang | ||||||||||
| PMID: | 28632999 | ||||||||||
| 32. | |||||||||||
| Journal: | Pathology. 2018 Oct;50(6):607-612. | ||||||||||
| Title: | Immunological environment in colorectal cancer: a computer-aided morphometric study of whole slide digital images derived from tissue microarray. | ||||||||||
| Author: | Eyraud, Daniel|Granger, Benjamin|Bardier, Armelle|Loncar, Yann|Gottrand, GaElle|Le Naour, Gilles|Siksik, Jean-Michel|Vaillant, Jean-Christophe|Klatzmann, David|Puybasset, Louis|Charlotte, Frederic|Augustin, Jeremy | ||||||||||
| PMID: | 30166125 | ||||||||||
| 33. | |||||||||||
| Journal: | Biol Pharm Bull. 2018;41(8):1243-1250. | ||||||||||
| Title: | Celastrol Suppresses Tryptophan Catabolism in Human Colon Cancer Cells as Revealed by Metabolic Profiling and Targeted Metabolite Analysis. | ||||||||||
| Author: | Qi, Yunpeng|Wang, Renping|Zhao, Liang|Lv, Lei|Zhou, Fan|Zhang, Tian|Lu, Feng|Yan, Hongli|Duan, Gengli | ||||||||||
| PMID: | 30068874 | ||||||||||
| 34. | |||||||||||
| Journal: | Adv Mater. 2018 Sep;30(38):e1803001. | ||||||||||
| Title: | Binary Cooperative Prodrug Nanoparticles Improve Immunotherapy by Synergistically Modulating Immune Tumor Microenvironment. | ||||||||||
| Author: | Feng, Bing|Zhou, Fangyuan|Hou, Bo|Wang, Dangge|Wang, Tingting|Fu, Yuanlei|Ma, Yuting|Yu, Haijun|Li, Yaping | ||||||||||
| PMID: | 30063262 | ||||||||||
| 35. | |||||||||||
| Journal: | Nat Biotechnol. 2018 Sep;36(8):758-764. | ||||||||||
| Title: | Reversal of indoleamine 2,3-dioxygenase-mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme. | ||||||||||
| Author: | Triplett, Todd A|Garrison, Kendra C|Marshall, Nicholas|Donkor, Moses|Blazeck, John|Lamb, Candice|Qerqez, Ahlam|Dekker, Joseph D|Tanno, Yuri|Lu, Wei-Cheng|Karamitros, Christos S|Ford, Kyle|Tan, Bing|Zhang, Xiaoyan M|McGovern, Karen|Coma, Silvia|Kumada, Yoi | ||||||||||
| PMID: | 30010674 | ||||||||||
| 36. | |||||||||||
| Journal: | Oncotarget. 2018 May 18;9(38):25216-25224. | ||||||||||
| Title: | Peritumoral endothelial indoleamine 2, 3-dioxygenase expression is an early independent marker of disease relapse in colorectal cancer and is influenced by DNA mismatch repair profile. | ||||||||||
| Author: | Meireson, Annabel|Chevolet, Ines|Hulstaert, Eva|Ferdinande, Liesbeth|Ost, Piet|Geboes, Karen|De Man, Marc|Van de Putte, Dirk|Verset, Laurine|Kruse, Vibeke|Demetter, Pieter|Brochez, Lieve | ||||||||||
| PMID: | 29861865 | ||||||||||
| 37. | |||||||||||
| Journal: | World J Gastroenterol. 2018 May 28;24(20):2181-2190. | ||||||||||
| Title: | Indoleamine-2,3-dioxygenase 1/cyclooxygenase 2 expression prediction for adverse prognosis in colorectal cancer. | ||||||||||
| Author: | Ma, Wen-Juan|Wang, Xing|Yan, Wen-Ting|Zhou, Zhong-Guo|Pan, Zhi-Zhong|Chen, Gong|Zhang, Rong-Xin | ||||||||||
| PMID: | 29853736 | ||||||||||
| 38. | |||||||||||
| Journal: | Ann Surg Oncol. 2018 Aug;25(8):2323-2331. | ||||||||||
| Title: | Cytolytic Activity Score to Assess Anticancer Immunity in Colorectal Cancer. | ||||||||||
| Author: | Narayanan, Sumana|Kawaguchi, Tsutomu|Yan, Li|Peng, Xuan|Qi, Qianya|Takabe, Kazuaki | ||||||||||
| PMID: | 29770915 | ||||||||||
| 39. | |||||||||||
| Journal: | J Hematol Oncol. 2018 Apr 23;11(1):58. | ||||||||||
| Title: | miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy. | ||||||||||
| Author: | Huang, Qian|Xia, Jiajia|Wang, Lei|Wang, Xu|Ma, Xiaodong|Deng, Qipan|Lu, Yong|Kumar, Munish|Zhou, Zhiyuan|Li, Ling|Zeng, Zhaoyang|Young, Ken H|Yi, Qing|Zhang, Mingzhi|Li, Yong | ||||||||||
| PMID: | 29685162 | ||||||||||
| 40. | |||||||||||
| Journal: | Int J Cancer. 2018 Sep 15;143(6):1516-1529. | ||||||||||
| Title: | 1-L-MT, an IDO inhibitor, prevented colitis-associated cancer by inducing CDC20 inhibition-mediated mitotic death of colon cancer cells. | ||||||||||
| Author: | Liu, Xiuting|Zhou, Wei|Zhang, Xin|Ding, Yang|Du, Qianming|Hu, Rong | ||||||||||
| PMID: | 29607498 | ||||||||||
| 41. | |||||||||||
| Journal: | J Cancer Res Clin Oncol. 2018 Jun;144(6):1005-1014. | ||||||||||
| Title: | CD274, LAG3, and IDO1 expressions in tumor-infiltrating immune cells as prognostic biomarker for patients with MSI-high colon cancer. | ||||||||||
| Author: | Lee, Soo Jung|Jun, Sun-Young|Lee, In Hee|Kang, Byung Woog|Park, Su Yeon|Kim, Hye Jin|Park, Jun Seok|Choi, Gyu-Seog|Yoon, Ghilsuk|Kim, Jong Gwang | ||||||||||
| PMID: | 29520442 | ||||||||||
| 42. | |||||||||||
| Journal: | Cell Death Dis. 2018 Mar 2;9(3):355. | ||||||||||
| Title: | Indoleamine 2,3-dioxygenase expression regulates the survival and proliferation of Fusobacterium nucleatum in THP-1-derived macrophages. | ||||||||||
| Author: | Xue, Ying|Xiao, Han|Guo, Songhe|Xu, Banglao|Liao, Yuehua|Wu, Yixian|Zhang, Ge | ||||||||||
| PMID: | 29500439 | ||||||||||